Craneware

Craneware

Craneware was founded in 1978 under a different name and pivoted to healthcare revenue-cycle management software in the late 1990s. Keith Neilson joined as CEO in 1998, taking the company public on the London Stock Exchange in 2007, where it trades under ticker CRW. The underlying wealth stems from Craneware's successful capture of the US hospital billing-software market, a segment dominated by legacy vendors. Craneware's strategy centers on cloud-based revenue-cycle management software for acute-care hospitals. The firm's platform, Trisus, covers charge capture, chargemaster management, contract modeling, and claims optimization. In 2022, Craneware acquired Sentry Healthcare Intelligence for an undisclosed sum, adding data analytics capabilities to its stack (per SEC filing, 2022). The largest known deployment is the acquisition of the US-based company in 2021, giving direct exposure to over 1,200 US hospital clients. Geographic footprint is primarily US-focused, with development and support operations in Edinburgh, Scotland. Craneware's revenue in its fiscal year ending June 2024 was approximately $195M, as publicly reported, with over 600 employees globally. The firm runs no separate family office vehicles disclosed; it operates as a publicly traded corporation with a traditional corporate structure. An adjacent philanthropic vehicle, the Craneware Charitable Trust, was established in 2015 and supports healthcare education and community health initiatives in Scotland and the United States. In May 2024, Craneware reported that its Trisus platform now processes over $60B in gross patient revenue annually (per the firm's May 2024 investor presentation). A structural differentiator for Craneware is its market position as the only publicly traded, pure-play hospital revenue-cycle software provider headquartered outside the US, deriving over 95% of revenue from the American healthcare system. This cross-Atlantic architecture allows it to operate without the regulatory overhead of a US-based company while competing directly with Oracle Health and Epic Systems. The firm's succession is board-managed under Neilson's continued leadership, with no single-family-office structure mediating ownership.